Zhou Luyi, Sun Wei-Lun, See Ronald E
Department of Neurosciences, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
Pharmaceuticals (Basel). 2011 Jun 14;4(6):804-821. doi: 10.3390/ph4060804.
Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors offers a promising target for addiction treatment. Growing evidence has implicated an important role of the orexin/hypocretin system in drug reward and drug-seeking, including animal models of relapse. Here, we review the evidence for the role of orexins in modulating reward and drug-seeking in animal models of addiction and the potential for orexin receptors as specific targets for anti-relapse medication approaches.
药物成瘾是一种以高复发率为特征的慢性疾病。在一段时间的戒断后,再次接触与药物相关的线索、应激事件或药物本身都可能引发复吸。通过药物干预来减轻引发复吸因素的影响,为成瘾治疗提供了一个有前景的靶点。越来越多的证据表明,食欲素/下丘脑泌素系统在药物奖赏和觅药行为中发挥重要作用,包括在复吸的动物模型中。在此,我们综述了食欲素在成瘾动物模型中调节奖赏和觅药行为方面作用的证据,以及食欲素受体作为抗复吸药物治疗特定靶点的潜力。